10/19/2026
🚨 BIG NEWS FOR MEDICARE BENEFICIARIES! 💊💙
Did you know that Medicare has introduced a new program that may help eligible beneficiaries access certain weight-loss medications for just $50 per month?
It's called the Medicare GLP-1 Bridge Program, and it's something Medicare beneficiaries should know about!
✅ Which medications are included?
• Wegovy
• Zepbound (KwikPen only)
• Foundayo
💰 What's the cost?
Eligible individuals pay $50 per month without having to meet their Medicare Part D deductible first.
👥 Who may qualify?
Eligibility depends on factors such as your BMI, certain medical conditions, and Medicare prescription drug coverage. Your doctor must submit a prior authorization request.
⚠️ Here's what you need to know:
✔️ The program is currently scheduled to run through December 31, 2027.
✔️ The $50 payment does not count toward your Medicare Part D deductible or annual out-of-pocket limit.
✔️ Mounjaro and Ozempic are not included in the Bridge Program, although they may be covered under regular Part D benefits for certain conditions.
✔️ Not every Medicare beneficiary will qualify.
💙 At C&J Isbell Brokerage Group, we believe Medicare education matters!
Understanding your benefits, medication costs, and available programs can make a real difference.
Whether you're already taking a GLP-1 medication or simply want to understand your Medicare options, I'm here to help answer your questions.
📞 James Isbell
C&J Isbell Brokerage Group LLC
📧 [email protected]
🌐 www.cjisbellbrokerage.com
🔗 Learn more from Medicare:
https://www.medicare.gov/coverage/weight-loss-drugs
This post is for educational purposes only. Eligibility and coverage restrictions apply. C&J Isbell Brokerage Group LLC is an independent insurance brokerage and is not affiliated with or endorsed by Medicare or the federal government.